Incident counts of reported ESRD, 2016 Q1 - 2018 Q3 |
|
2016^
|
2017^
|
2018^
|
Qtr1 |
Qtr2 |
Qtr3 |
Qtr4 |
Qtr1 |
Qtr2 |
Qtr3 |
Qtr4 |
Qtr1 |
Qtr2 |
Qtr3 |
0 - 19 |
286 |
275 |
274 |
270 |
264 |
260 |
268 |
260 |
236 |
257 |
264 |
20 - 44 |
3,758 |
3,568 |
3,313 |
3,470 |
3,644 |
3,554 |
3,237 |
3,391 |
3,650 |
3,468 |
3,211 |
45 - 64 |
12,826 |
12,021 |
11,285 |
11,729 |
12,698 |
11,829 |
11,210 |
11,687 |
12,434 |
11,644 |
10,561 |
65 - 74 |
9,008 |
8,603 |
7,978 |
8,297 |
8,823 |
8,598 |
8,047 |
8,434 |
9,159 |
8,687 |
7,698 |
75 + |
7,732 |
7,158 |
6,675 |
6,997 |
7,600 |
7,310 |
6,624 |
7,142 |
7,826 |
7,526 |
6,542 |
|
Male |
19,608 |
18,192 |
17,020 |
17,876 |
19,306 |
18,308 |
17,099 |
18,014 |
19,650 |
18,434 |
16,292 |
Female |
14,002 |
13,433 |
12,505 |
12,887 |
13,723 |
13,243 |
12,287 |
12,900 |
13,655 |
13,148 |
11,984 |
|
Diabetes |
15,948 |
14,824 |
13,792 |
14,593 |
15,683 |
14,661 |
13,746 |
14,586 |
15,861 |
14,675 |
12,836 |
Hypertension |
9,384 |
8,875 |
8,422 |
8,783 |
9,409 |
9,124 |
8,546 |
8,955 |
9,551 |
9,218 |
7,921 |
Glomerulonephritis |
2,529 |
2,303 |
2,193 |
2,217 |
2,450 |
2,248 |
2,028 |
2,129 |
2,288 |
2,205 |
1,969 |
Cystic kidney |
933 |
946 |
870 |
844 |
907 |
895 |
865 |
842 |
868 |
861 |
832 |
Other urologic |
452 |
453 |
401 |
432 |
450 |
468 |
404 |
456 |
456 |
469 |
419 |
Other cause |
3,339 |
3,304 |
2,986 |
3,057 |
3,132 |
3,167 |
2,867 |
2,964 |
3,139 |
2,873 |
2,568 |
Unknown cause |
156 |
111 |
101 |
106 |
121 |
112 |
93 |
89 |
117 |
122 |
289 |
Missing cause |
869 |
809 |
760 |
731 |
877 |
876 |
837 |
893 |
1,025 |
1,159 |
1,442 |
|
All |
33,610 |
31,625 |
29,525 |
30,763 |
33,029 |
31,551 |
29,386 |
30,914 |
33,305 |
31,582 |
28,276 |
|
^ Data as of December 31, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
|
Point prevalent counts of reported ESRD, 2016 Q1 - 2018 Q3 |
|
2016^
|
2017^
|
2018^
|
Qtr1
|
Qtr2
|
Qtr3
|
Qtr4
|
Qtr1
|
Qtr2
|
Qtr3
|
Qtr4
|
Qtr1
|
Qtr2
|
Qtr3
|
0 - 19 |
7,722 |
7,731 |
7,727 |
7,676 |
7,672 |
7,653 |
7,623 |
7,624 |
7,576 |
7,589 |
7,589 |
20 - 44 |
106,634 |
106,850 |
106,663 |
106,675 |
106,921 |
107,385 |
107,196 |
107,183 |
107,566 |
107,945 |
107,731 |
45 - 64 |
314,394 |
316,614 |
318,037 |
319,270 |
321,292 |
323,095 |
323,894 |
324,824 |
326,165 |
327,732 |
328,172 |
65 - 74 |
171,076 |
173,941 |
176,069 |
178,268 |
179,789 |
182,170 |
184,556 |
186,214 |
187,787 |
189,864 |
191,384 |
75 + |
116,119 |
117,441 |
118,814 |
119,692 |
120,518 |
122,027 |
123,636 |
124,934 |
125,948 |
128,066 |
129,465 |
|
Male |
414,018 |
417,891 |
420,764 |
423,506 |
426,464 |
430,481 |
433,563 |
436,048 |
438,987 |
442,867 |
444,752 |
Female |
301,857 |
304,617 |
306,477 |
308,006 |
309,662 |
311,783 |
313,277 |
314,667 |
315,993 |
318,266 |
319,526 |
Unknown |
70 |
69 |
69 |
69 |
66 |
66 |
65 |
64 |
62 |
63 |
63 |
|
Diabetes |
274,660 |
277,695 |
279,766 |
281,590 |
283,698 |
286,277 |
288,084 |
289,555 |
291,148 |
293,489 |
294,230 |
Hypertension |
183,360 |
185,284 |
186,890 |
188,364 |
189,680 |
191,546 |
193,134 |
194,480 |
195,921 |
197,964 |
198,902 |
Glomerulonephritis |
114,191 |
114,649 |
115,001 |
115,285 |
115,665 |
116,068 |
116,252 |
116,524 |
116,856 |
117,322 |
117,476 |
Cystic kidney |
34,092 |
34,579 |
34,985 |
35,376 |
35,753 |
36,160 |
36,573 |
36,917 |
37,247 |
37,598 |
37,892 |
Other urologic |
11,652 |
11,781 |
11,845 |
11,953 |
12,022 |
12,143 |
12,205 |
12,305 |
12,387 |
12,526 |
12,606 |
Other cause |
62,372 |
63,079 |
63,422 |
63,784 |
64,119 |
64,807 |
65,229 |
65,515 |
65,818 |
66,181 |
66,230 |
Unknown cause |
23,796 |
23,370 |
22,934 |
22,481 |
22,061 |
21,679 |
21,331 |
20,955 |
20,589 |
20,318 |
20,226 |
Missing cause |
11,822 |
12,140 |
12,467 |
12,748 |
13,194 |
13,650 |
14,097 |
14,528 |
15,076 |
15,798 |
16,779 |
|
All |
715,945 |
722,577 |
727,310 |
731,581 |
736,192 |
742,330 |
746,905 |
750,779 |
755,042 |
761,196 |
764,341 |
|
^ Data as of December 31, 2018
* Suppressed due to inadequate sample size.
. Zero values in this cell.
|
Reported Medical Evidence Form data for the incident ESRD population, 2016 Q1 - 2018 Q3 |
|
2016^
|
2017^
|
2018^
|
Qtr1 |
Qtr2 |
Qtr3 |
Qtr4 |
Qtr1 |
Qtr2 |
Qtr3 |
Qtr4 |
Qtr1 |
Qtr2 |
Qtr3 |
White |
22,201 |
20,797 |
19,519 |
20,450 |
21,486 |
20,830 |
19,208 |
20,269 |
21,926 |
20,573 |
18,070 |
Black/African American |
8,536 |
8,118 |
7,419 |
7,708 |
8,536 |
7,825 |
7,462 |
7,752 |
8,230 |
7,782 |
6,951 |
Native American/Alaska Native |
306 |
326 |
292 |
287 |
327 |
292 |
264 |
306 |
302 |
348 |
315 |
Asian |
1,427 |
1,301 |
1,220 |
1,303 |
1,459 |
1,361 |
1,271 |
1,309 |
1,412 |
1,380 |
1,227 |
Pacific Islander |
421 |
407 |
396 |
361 |
397 |
393 |
351 |
393 |
419 |
358 |
314 |
Other/Unknown |
* |
* |
. |
. |
. |
* |
* |
* |
* |
* |
* |
No ME Form |
846 |
788 |
754 |
727 |
870 |
870 |
836 |
880 |
1,014 |
1,143 |
1,396 |
|
Hispanic |
4,950 |
4,403 |
4,028 |
4,269 |
4,530 |
4,414 |
4,145 |
4,336 |
4,797 |
4,591 |
3,863 |
Non-Hispanic |
27,941 |
26,547 |
24,817 |
25,839 |
27,675 |
26,288 |
24,411 |
25,694 |
27,493 |
25,850 |
23,014 |
Unknown |
* |
* |
* |
* |
. |
. |
* |
* |
* |
* |
* |
No ME Form |
846 |
788 |
754 |
727 |
870 |
870 |
836 |
880 |
1,014 |
1,143 |
1,396 |
|
Hemodialysis (%)1 |
90.32 |
89.79 |
89.16 |
90.27 |
90.23 |
89.26 |
88.92 |
89.3 |
89.27 |
88.17 |
87.84 |
CAPD (%)1 |
4.65 |
4.74 |
5.01 |
4.41 |
4.27 |
4.83 |
4.88 |
4.64 |
4.38 |
4.8 |
4.93 |
CCPD (%)1 |
5.02 |
5.45 |
5.81 |
5.29 |
5.49 |
5.9 |
6.18 |
6.05 |
6.34 |
7.02 |
7.22 |
Other (%)1 |
0.009 |
0.023 |
0.018 |
0.024 |
0.013 |
0.003 |
0.014 |
0.01 |
0.013 |
0.017 |
0.004 |
Unknown (%)1 |
. |
. |
. |
. |
. |
0.007 |
. |
. |
. |
. |
. |
|
Cathether Only (%)2 |
62.61 |
62.22 |
61.81 |
63.23 |
62.96 |
62.48 |
63.22 |
65.02 |
64.92 |
64.25 |
64.89 |
Catheter w/ maturing AVF (%)2 |
16.07 |
16.59 |
15.84 |
15.74 |
15.61 |
15.58 |
14.93 |
14.63 |
14.49 |
14.53 |
13.37 |
Catheter w/ maturing AVG (%)2 |
1.6 |
1.64 |
1.6 |
1.6 |
1.6 |
1.5 |
1.4 |
1.36 |
1.6 |
1.52 |
1.58 |
AVF (%)2 |
16.66 |
16.35 |
17.2 |
16.51 |
16.64 |
17.1 |
17.18 |
15.84 |
15.87 |
16.44 |
16.84 |
AVG (%)2 |
2.87 |
3.08 |
3.36 |
2.8 |
3.05 |
3.16 |
3.07 |
3.01 |
2.98 |
3.08 |
3.12 |
Other(%)2 |
0.15 |
0.088 |
0.18 |
0.12 |
0.13 |
0.16 |
0.18 |
0.12 |
0.1 |
0.15 |
0.13 |
Unknown(%)2 |
0.031 |
0.037 |
0.008 |
0.008 |
0.007 |
0.015 |
0.024 |
0.019 |
0.039 |
0.027 |
0.078 |
|
Pre-ESRD EPO(% Yes)3 |
19.88 |
19.9 |
20.15 |
20.26 |
20.05 |
21.2 |
21.14 |
21.12 |
21.73 |
22.53 |
23.36 |
Pre-ESRD Nephrology(% Yes)3 |
74.59 |
75.54 |
76.26 |
75.84 |
76.41 |
78.05 |
78.43 |
77.16 |
78.41 |
79.77 |
80.17 |
|
Mean Serum Albumin(g/dL)4 |
3.15 |
3.18 |
3.21 |
3.17 |
3.16 |
3.21 |
3.23 |
3.21 |
3.2 |
3.25 |
3.28 |
Mean Serum Creatinine(mg/dL)4 |
6.4 |
6.37 |
6.42 |
6.42 |
6.41 |
6.38 |
6.37 |
6.41 |
6.4 |
6.33 |
6.38 |
Mean Hemoglobin(g/dL)4 |
9.33 |
9.35 |
9.38 |
9.3 |
9.31 |
9.35 |
9.39 |
9.34 |
9.32 |
9.39 |
9.36 |
|
All |
33,739 |
31,741 |
29,600 |
30,836 |
33,075 |
31,572 |
29,393 |
30,916 |
33,309 |
31,586 |
28,278 |
All with ME Form |
32,893 |
30,953 |
28,846 |
30,109 |
32,205 |
30,702 |
28,557 |
30,036 |
32,295 |
30,443 |
26,882 |
Dialysis Pts with ME Form |
32,311 |
30,306 |
28,228 |
29,469 |
31,588 |
30,045 |
27,908 |
29,344 |
31,619 |
29,764 |
26,262 |
Hemodialysis Pts w/ ME Form |
29,182 |
27,213 |
25,169 |
26,603 |
28,503 |
26,817 |
24,817 |
26,203 |
28,226 |
26,242 |
23,069 |
|
^ Data as of December 31, 2018.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.
|
|